BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19789340)

  • 1. Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma.
    Dai B; Zhao XF; Hagner P; Shapiro P; Mazan-Mamczarz K; Zhao S; Natkunam Y; Gartenhaus RB
    Cancer Res; 2009 Oct; 69(19):7835-43. PubMed ID: 19789340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage.
    Nandi S; Reinert LS; Hachem A; Mazan-Mamczarz K; Hagner P; He H; Gartenhaus RB
    Oncogene; 2007 Apr; 26(16):2283-9. PubMed ID: 17016429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1.
    Chang G; Zheng J; Xiao W; Chang S; Wei Q; Wu H; Tao Y; Yang G; Xie B; Lan X; Wang Y; Yu D; Hu L; Xie Y; Bu W; Kong Y; Dai B; Hou J; Shi J
    Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):399-407. PubMed ID: 29534146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma.
    Bhalla S; Evens AM; Dai B; Prachand S; Gordon LI; Gartenhaus RB
    Blood; 2011 Jul; 118(4):1052-61. PubMed ID: 21628402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
    Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
    Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.
    Tjin EP; Groen RW; Vogelzang I; Derksen PW; Klok MD; Meijer HP; van Eeden S; Pals ST; Spaargaren M
    Blood; 2006 Jan; 107(2):760-8. PubMed ID: 16189274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine.
    Ghosh S; Adhikary A; Chakraborty S; Bhattacharjee P; Mazumder M; Putatunda S; Gorain M; Chakraborty A; Kundu GC; Das T; Sen PC
    J Biol Chem; 2015 Feb; 290(7):3936-49. PubMed ID: 25527500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
    Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
    J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity.
    Shih HJ; Chen HH; Chen YA; Wu MH; Liou GG; Chang WW; Chen L; Wang LH; Hsu HL
    Oncotarget; 2012 Nov; 3(11):1401-15. PubMed ID: 23211466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway.
    Liu WH; Liu HB; Gao DK; Ge GQ; Zhang P; Sun SR; Wang HM; Liu SB
    Cell Transplant; 2013; 22(10):1859-68. PubMed ID: 23032069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
    Huang Y; Zou Y; Lin L; Ma X; Zheng R
    Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma.
    Dai B; Zhao XF; Mazan-Mamczarz K; Hagner P; Corl S; Bahassi el M; Lu S; Stambrook PJ; Shapiro P; Gartenhaus RB
    Nat Commun; 2011 Jul; 2():402. PubMed ID: 21772273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
    Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
    Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
    Romerio F; Riva A; Zella D
    Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
    Kim EJ; Juhnn YS
    J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.